ABSTRACT: Chronic wasting disease (CWD) was first identified in Wisconsin (USA) in whitetailed deer (Odocoileus virginianus) in February 2002. To determine if prion protein gene (Prnp) allelic variability was associated with CWD in white-tailed deer from Wisconsin, we sequenced Prnp from 26 CWD-positive and 100 CWD-negative deer. Sequence analysis of Prnp suggests that at least 86-96% of the white-tailed deer in this region have Prnp allelic combinations that will support CWD infection. Four Prnp alleles were identified in the deer population, one of which, resulting in a glutamine to histidine change at codon 95, has not been previously reported. The predominant allele in the population encodes for glutamine at codon 95, glycine at codon 96, and serine at codon 138 (QGS). Less abundant alleles encoded QSS, QGN, and HGS at the three variable positions. Comparison of CWD-positive with CWD-negative deer suggested a trend towards an over-representation of the QGS allele and an under-representation of the QSS allele.
INTRODUCTION

Chronic wasting disease
Chronic wasting disease (CWD) is the cervid form of an unconventional group of diseases known as transmissible spongiform encephalopathies (TSE). Prion diseases, or TSEs, are characterized by the accumulation of protease-resistant prion protein termed PrP TSE in the brains of affected animals. Protease-resistant prion protein accumulates via conversion of the normal cellular prion protein (PrP C ) to the disease-associated isoform.
CWD was first detected in captive mule deer (Odocoileus hemionus hemionus) in Colorado (Williams and Young, 1980) and, subsequently, in free-ranging deer and elk (Cervus elaphus) in southeastern Wyoming and northeastern Colorado. In 2001, the range of the disease in wild deer extended to western Nebraska. As of February 2003, CWD had been identified in free-ranging deer in Illinois, New Mexico, Saskatchewan, South Dakota, Utah, and Wisconsin as well as Wyoming, Colorado, and Nebraska. It has also been identified in farm-raised elk and/or deer in Colorado, Nebraska, Alberta, Saskatchewan, Kansas, Montana, Minnesota, South Dakota, Oklahoma, and Wisconsin.
In Wisconsin, CWD was first detected in free-ranging white-tailed deer (Odocoileus virginianus) in the south-central portion of the state in February 2002. In response, the Wisconsin Department of Natural Resources (DNR) initiated a surveillance program in the region. Of the initial 476 white-tailed deer tested using immunohistochemistry, 15 were brainstem (obex) and/or retropharyngeal lymph node positive for PrP CWD . By August 2002, 40/2,476 free-ranging deer had tested positive for CWD (J. Langenberg, pers. comm.).
Genetic susceptibility
The link between Prnp variability and susceptibility to prion diseases has been demonstrated in domestic animals, experimental animal models, and in human forms of the prion disease. A genetic susceptibility factor in mice, the scrapie incubation gene (Sinc), was identified by genetic and transmission studies (Dickinson et al., 1968) . Subsequent molecular analyses identified a single amino acid change in the prion protein of mice exhibiting different incubation phenotypes (Westaway et al., 1987) . Similar to the Sinc gene in mice, the scrapie incubation period gene (Sip) was linked to scrapie susceptibility in sheep (Dickinson and Outram, 1988) . Amino acid polymorphisms at positions 136, 154, and 171 in sheep PrP have been linked to development of both natural and experimental scrapie (Hunter et al., 1997) .
Three mechanisms of contracting prion disease in humans are typically described: sporadic, familial, and iatrogenic. A fourth, the consumption of bovine spongiform encephalopathy (BSE) agent, appears to be the cause of variant CJD (vCJD). In all forms of human prion diseases, a Prnp polymorphism at codon 129 (encoding for methionine or valine) affects susceptibility or disease presentation (reviewed in Ková cs et al., 2002 and Prusiner, 1999) . In the case of vCJD, all confirmed cases have occurred in individuals homozygous for methionine at codon 129 (Asante et al., 2002) . In addition to the codon 129 polymorphism, more than 20 different Prnp polymorphisms have been linked to familial forms of the disease in humans. It is unknown how these polymorphisms contribute to disease formation. Polymorphisms that result in PrP amino acid changes are strongly linked to unique phenotypic presentations of the disease.
PrP gene variability in cervids
Previous studies identified Prnp polymorphisms in elk and deer at codon positions 96, 132, 138, and 226 (O'Rourke et al., 1999; Raymond et al., 2000) . Elk differ from white-tailed and mule deer at codon 226 and exhibit variability in codon 132. Both white-tailed and mule deer are polymorphic at codon 138, while heterogeneity at codon 96 is unique to white-tailed deer. Polymorphisms in Prnp could affect CWD susceptibility in cervids, impacting the degree to which cervid populations are vulnerable to disease transmission and progression. O'Rourke et al. (1999) It is not known if Prnp polymorphisms affect the susceptibility of white-tailed deer to CWD. To address this question, we initiated a study to determine if specific Prnp polymorphisms are associated with the presence of CWD in the CWD-affected region of south-central Wisconsin. The prion protein gene was sequenced from 26 CWD-positive and 100 CWD-negative white-tailed deer from the south-central Wisconsin CWD Eradication Zone. Four Prnp alleles were identified. Specific Prnp alleles were observed to be associated with CWD-positive white-tailed deer.
MATERIALS AND METHODS
Tissues
All tissue samples were provided by the Wisconsin Department of Natural Resources and were obtained from deer harvested within the 1064 km 2 CWD-affected region in Dane and Iowa counties of south-central Wisconsin. Deer were harvested between March 2002 and September 2002 except two CWD-positive deer that were harvested in the fall of 2001. Blood and ear tissues were collected from deer heads previously sampled for CWD by the Wisconsin DNR. Obex and retropharyngeal lymph nodes were tested for the presence of PrP CWD using immunohistochemistry (IHC) at the National Veterinary Services Laboratories in Ames, Iowa (USA). Deer defined as CWD-positive stained positive for PrP CWD in the obex and/or retropharyngeal lymph nodes. Deer defined as CWD-negative were animals that were obex and lymph node IHC-negative for proteinase K resistant PrP (Julia Langenberg, pers. comm.).
Isolation of genomic DNA
Genomic white-tailed deer DNA was isolated from blood using the DNA IQ System (Promega, Madison, Wisconsin). Manufacturer's instructions were followed with the exception of an additional lysis buffer wash. Genomic DNA was isolated from ear tissue by incubating 10-25 mg tissue in 100 l digestion solution (800 l digestion buffer [10 mM EDTA, 0.1% SDS, and 1 mM Tris pH 9.0], 100 l 1M DTT, and 100 l proteinase K [18 mg/ml]) for 1-2 hr at 56 C, vortexing every 15 min. Samples were then centrifuged at 8,200ϫG for 5 min. The resulting supernatant was added to 50 l DNA IQ lysis buffer and 7 l magnetic beads (Promega) and incubated for 5 min at room temperature. Samples were rinsed once with lysis buffer and three times with the wash buffer, using the magnetic stand between each wash to separate the beads from supernatant. Genomic DNA was then eluted from the beads as per the manufacturer's instructions. , and 72 C (1.5 min) followed by 25 cycles at 95 C (45 sec), 57 C (45 sec), and 72 C (1.5 min), and a final extension at 72 C (5 min). Amplified product was gel purified using QIAquick kit (Qiagen, Valencia, California) and sequenced at the University of Wisconsin-Madison Biotechnology Center using dideoxy terminator sequencing. Primer pairs CWD-21, -801, -161 (5Ј-AG-GGAAGTCCTGGAGGCAA CCGCTATCC-3Ј [forward]), and -418 (5Ј-CACCAAGGCCCC-CTACCACTGCTCCA GC-3Ј [reverse]), or CDW-13, -LA, -161, and -418 were used for sequencing. Sequence was analyzed using Editview and MacVector 6.5 software.
Bae I digestion
The restriction endonuclease Bae I (New England Biolabs, Beverly, Massachusetts, USA) was used to confirm the presence of an A to C nucleotide (nt) change at nt 315. Amplification products (1 g) were incubated with five units Bae I (5Ј . . . 10/7 [N]ACNNNNGTAPy C [N] 12/7 . . . 3Ј) as per the manufacturer's instructions. Following digestion, Bae I was inactivated by incubating at 65 C for 20 min. Digestion products were separated on a 1% agarose gel, stained with ethidium bromide, and visualized using UV light.
Statistical analysis
To estimate the proportion of the whitetailed deer population in the CWD-affected region that are genetically susceptible to CWD, we constructed a 95% confidence interval based on a large-sample approximation to the binomial distribution using the frequency of allelic combinations in the CWD-negative population.
RESULTS
Prion protein variability in white-tailed deer
The PrP gene was sequenced from 26 CWD-positive and 100 CWD-negative free-ranging white-tailed deer from the 1064 km 2 CWD-affected region of Wisconsin. We identified 14 Prnp DNA polymorphisms. Three of these polymorphisms, at codon positions 95, 96, and 138, change the amino acid sequence of the prion protein. The majority of deer (87.3%) had at least one copy of the glutamine (95), glycine (96), and serine (138) PrP allele (QGS). This allele has been referred to as wild-type (Raymond et al., 2000) . Other alleles identified in the 1064 km 2 affected region include QSS and QGN, both of which have been characterized elsewhere (Raymond et al., 2000) . In addition, we identified a fourth, relatively rare allele, HGS, in three of the animals tested.
The adenine to cytosine change at nt 315 of the deer Prnp, resulting in a glutamine to histidine change at amino acid 95, produced a unique restriction endonuclease site, Bae I, on the genome. Amplified Prnp from deer heterozygous for the HGS allele exhibited appropriately sized digestion products (500 and 300 bp) (Fig. 1) . Since both deer are heterozygous for histidine, one-half of the amplified product encodes a glutamine and did not digest with Bae I. Amplified Prnp from deer homozygous for glutamine at position 95 was not cleaved by the restriction endonuclease.
All CWD-positive deer sequenced were QGS/QGS, QGS/QGN, QGS/QSS, or QSS/QGN allele combinations (Fig. 2) . Sequence analysis of cloned amplification products from at least one of the putative double heterozygotes confirmed the assignment of the polymorphisms (data not shown). The combinations found in CWDpositive deer comprise 91% of the CWDnegative deer tested. When extrapolated at a 95% confidence interval, 91Ϯ5% of the CWD-negative deer in the affected region encode Prnp alleles that will facilitate infection.
The majority of PrP alleles in deer from CWD-positive (86.5%) and CWD-negative (68.0%) populations were QGS. Seventy-seven percent of the CWD-positive deer were QGS/QGS, whereas 47% of the CWD-negative deer were QGS/QGS. The QSS allele appears to be under-represented in the CWD-positive deer population. Twenty-four percent of the Prnp alleles are QSS in CWD-negative deer while comprising 9.6% of the PrP alleles in CWD-positive deer (Fig. 3) . Deer homozygous for QSS represent 6% of the CWD-negative deer (Fig. 2) . We have not identified a CWD-positive deer with the QSS/QSS allele.
DISCUSSION
This study indicates that the majority of white-tailed deer in the CWD-affected area of south-central Wisconsin have Prnp allelic combinations that are found in CWD-positive deer suggesting that there is little to no molecular barrier to CWD infection in this region. The Prnp allelic combinations present in the CWD-positive deer suggest that at least 86% to 96% of the white-tailed population in the affected region are susceptible to CWD.
Susceptibility factors
The QGS and QSS alleles constitute the majority of the PrP alleles (92.8%) in deer from the eradication zone that were tested. Although no significant differences were found, trends suggest that QSS is under-represented in the CWD-positive population. We found this disparity of allelic representation somewhat surprising given that previous in vitro cell-free conversion data indicated little or no molecular barrier to conversion of the QSS allele to the proteinase K resistant form (Raymond et al., 2000) . It is possible that the presence of the QSS allele slows disease progression by reducing the number of deer harboring detectable levels of infectious agent. We have, however, identified one CWD-positive deer that was QSS/QGN, indicating that either the QSS and/or the QGN proteins can be converted to the infectious form.
Potential for CWD strains
Deer homozygous for the QGS allele comprised the majority of the CWD-positive animals sequenced. White-tailed deer encoding QGS/QGN and QGS/QSS PrP variants have also tested positive for CWD. It is possible, in heterozygous deer, that the QSS and/or QGN proteins are being converted to an infectious form. Identification of a CWD-positive QSS/QGN deer suggests there is infectious PrP agent present in the population containing either the QSS or QGN protein. In addition to potentially changing the susceptibility/resistance of deer that carry these alleles, variations in the primary protein sequence may also affect transmission properties of the agent. For example, an animal of another species, resistant to infectious agent passed in QGS/QGS deer, may be susceptible to agent from a homozygous or heterozygous deer carrying another allele. It is not known whether different CWD strains exist. The inability to efficiently transmit the disease to rodents has limited such studies. Cell-free conversion experiments in which polymorphic deer PrP C proteins were incubated in the presence of PrP CWD suggest that distinct differences in conversion efficiencies exist (Raymond et al., 2000) . In sheep, a single amino acid change in PrP Sc resulted in altered abilities to convert PrP C by cell-free conversion .
Management implications of this study
The geographic range of CWD is expanding. The apparent resistance of sheep, with specific Prnp alleles, to specific strains of scrapie has led to suggestions that genetic resistance may be a means of managing CWD in free-ranging whitetailed deer. Our data, as well as data from elk Prnp analyses, suggest that genetic resistance, based on changes in the prion protein, is not a viable option as a management tool.
CONCLUSION
A number of factors contribute to the epidemiology of CWD in free-ranging white-tailed deer including: 1) contagious nature of the CWD agent, 2) extended preclinical stage of the disease, 3) deer density and movement, 4) resistance of the infectious agent to inactivation, 5) degree of human intervention (both positive and negative) and 6) genetic susceptibility to the disease. Given that the majority of the deer present in the CWD-affected region of south-central Wisconsin are susceptible to CWD and the contagious nature of the disease, a continued increase in the prevalence and the range of CWD are likely.
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